Jean-claude C. Tardif
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Jean-claude C. Tardif

Montreal, QC, CA 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Jean-claude Tardif practices in Montreal, Canada. Mr. Tardif is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Acute Coronary Syndrome, Atherosclerosis, Coronary Heart Disease, Angioplasty, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 572 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Montreal, QC, Canada
Other Locations
Canada
2900 Edouard Montpetit Blvd, Montreal, Quebec, QC H3T1J4, Canada
Halifax, NS, Canada
London, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2025
Intervention Type: Other, Diagnostic test
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Enrollment Status: Terminated
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 3
EValuation of Outcomes of MitraCLip for the Treatment of Moderate Functional Mitral ValvE Regurgitation In Heart Failure
EValuation of Outcomes of MitraCLip for the Treatment of Moderate Functional Mitral ValvE Regurgitation In Heart Failure
Enrollment Status: Terminated
Publish Date: May 30, 2024
Intervention Type: Device, Drug
Study Phase: Not Applicable
Preliminary Evaluation of the Capacity of a Metabolic Hyperspectral Retinal Camera (MHRC) to Identify an Arteriosclerosis Spectral Signature in Retinal Arterioles
Preliminary Evaluation of the Capacity of a Metabolic Hyperspectral Retinal Camera (MHRC) to Identify an Arteriosclerosis Spectral Signature in Retinal Arterioles
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study To Compare The Efficacy And Safety Of High-Medium Molecular Weight Beta-Glucan As Add-On To Statin Therapy In Subjects With Hyperlipidemia.
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study To Compare The Efficacy And Safety Of High-Medium Molecular Weight Beta-Glucan As Add-On To Statin Therapy In Subjects With Hyperlipidemia.
Enrollment Status: Completed
Publish Date: January 16, 2024
Intervention Type: Drug
Study Drug: CP105F
Study Phase: Phase 2
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Project I-A of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Project I-A of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Other
Study Phase: Not Applicable
Colchicine Cardiovascular Outcomes Trial (COLCOT)
Colchicine Cardiovascular Outcomes Trial (COLCOT)
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
Non-isotope Based Imaging Modalities vs 99mTcSPECT to Detect Myocardial Ischemia in Patients at High Risk for Ischemic Cardiovascular Events
Non-isotope Based Imaging Modalities vs 99mTcSPECT to Detect Myocardial Ischemia in Patients at High Risk for Ischemic Cardiovascular Events
Enrollment Status: Completed
Publish Date: February 21, 2020
Computed Tomographic Coronary Angiography for Heart Failure Patients (CTA -HF) Project I-C of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Computed Tomographic Coronary Angiography for Heart Failure Patients (CTA -HF) Project I-C of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Other
Study Phase: Not Applicable
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure (OUTSMART-HF) Project I-B of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure (OUTSMART-HF) Project I-B of Imaging Modalities to Assist With Guiding Therapy and the Evaluation of Patients With Heart Failure (IMAGE-HF)
Enrollment Status: Completed
Publish Date: November 21, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

567 Total Publications

Manganese homeostasis modulates glucan and chitin unmasking in the opportunistic yeast Candida albicans.
Manganese homeostasis modulates glucan and chitin unmasking in the opportunistic yeast Candida albicans.
Journal: Virulence
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tardif's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 13 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile